After 4 years the basaloid type squamous cells from Tonsil Cancer have presented themselves in my liver. There is one large tumor and two smaller ones. The outlook is 3 months without treatment and 10 months with treatments. No one,of course, can say for sure how long you will live. The treatment I chose is Methotrexate. An injection once a week, with very little side effects. The other choice was cisplatin, we all know about cisplatin! The benefits of ciplatin were not much better than Methotrexate. So I chose the one with the least side effects. I had my first shot on Wednesday. and I have to say, I could feel it working right away. It went right away to my liver, which is just below your breastbone, I always thought it was lower and also I could feel it in my neck where I had surgery for the original. It is reducing the size of the tumor.I can feel that it is smaller when I lay on my stomach.I am trying to get an appointment here with a liver specialist, but the medical oncologist(chemo doctor) thinks the mass might be too large for surgery. So I've contacted friends in New York City who work for years in Hospital Administration, to see if a specialist in New York might have some other ideas. I feel as though the Methotrexate is just a standard palliative practice. And is not intended to prolong my lifespan. The paradox is that even if you shink the tumors by 50, 60% it doesn't increase longievty. All this is very unusual here, out of 1000 patients only 8 have had distant mets, mostly to lungs,bone and liver. I'm the only one with just liver mets. Has anyone out there heard of this and someone who survived? By the way, check your stomach area if you feel any hard mass get it looked at! I only had CTScans to the head and neck alone. Thanks, Tom Roussell


SCC Tonsil Rt T3 N2b M0 side DX Jan 04 Tx 36 Rad 3 cisplatin Tx ending May 04. partial neck dissection july 04..... July 15,08 mets to liver Age 57...Did Methotrexate Sept 08. Now on a trial drug Panitumumab, Feb4,09 treatments stopped. going to Tibetan Medicine.